AllianceBernstein
ACUR

AllianceBernstein’s Acura Pharmaceuticals ACUR Stock Holding History

AllianceBernstein’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-215
Closed -$2K – 3781
2014
Q1 		$2K Hold
215
– – ﹤0.01% 3493
2013
Q4 		$2K Sell
215
-2
-0.9% -$17 ﹤0.01% 3286
2013
Q3 		$2K Sell
217
-3,475
-94% -$30.7K ﹤0.01% 3309
2013
Q2 		$35K Buy
+3,692
New +$41.7K ﹤0.01% 3023

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Cortland Associates St Louis, Missouri $697M AUM 4.23% 1-Year Est. Return

AllianceBernstein's ACUR Position: Q2 2014 in Review

AllianceBernstein sold out of Acura Pharmaceuticals (ACUR) in Q2 2014, closing a stake of 215 shares — an estimated $2K sold.

AllianceBernstein first reported a position in ACUR in Q2 2013 and held it in 4 quarters. The position peaked at $35K in Q2 2013. 33 funds tracked by Wall St. Rank hold ACUR as of Q2 2014.

  • AllianceBernstein reported no remaining Acura Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • AllianceBernstein sold 215 Acura Pharmaceuticals shares in Q2 2014, an estimated $2K.
  • AllianceBernstein first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • AllianceBernstein's Acura Pharmaceuticals position peaked at $35K in Q2 2013.
  • 33 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.